Candel Therapeutics, Inc. (CADL) vs Immix Biopharma, Inc. (IMMX)
Candel Therapeutics, Inc. and Immix Biopharma, Inc. are both Biotechnology companies. Candel Therapeutics, Inc. and Immix Biopharma, Inc. are of similar size ($883.8M and $844.3M). Across the 9 metrics below, Immix Biopharma, Inc. leads on 7 and Candel Therapeutics, Inc. on 2.
Valuation
Profitability
| Metric | CADL | IMMX | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | — | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (81.84%) | (34.18%) | (57.72%) |
| Return on assets | (56.37%) | (31.34%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack